BENDETOWICZ, David; FABBRI, Margherita; SIRNA, Federico; FERNAGUT, Pierre-Olivier; SAMIER FOUBERT, Alexandra; SAULNIER, Tiphaine; LE TRAON, Anne Pavy; PROUST LIMA, Cecile; RASCOL, Olivier; MEISSNER, Wassilios

doi:10.1007/s11910-024-01335-0

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

BENDETOWICZ, David
Institut des Maladies Neurodégénératives [Bordeaux] [IMN]

FABBRI, Margherita

SIRNA, Federico

Langue

Article de revue

Ce document a été publié dans

Current Neurology and Neuroscience Reports. 2024-02-28

Résumé en anglais

PURPOSE OF REVIEW: This review summarizes previous and ongoing neuroprotection trials in multiple system atrophy (MSA), a rare and fatal neurodegenerative disease characterized by parkinsonism, cerebellar, and autonomic dysfunction. It also describes the preclinical therapeutic pipeline and provides some considerations relevant to successfully conducting clinical trials in MSA, i.e., diagnosis, endpoints, and trial design. RECENT FINDINGS: Over 30 compounds have been tested in clinical trials in MSA. While this illustrates a strong treatment pipeline, only two have reached their primary endpoint. Ongoing clinical trials primarily focus on targeting α-synuclein, the neuropathological hallmark of MSA being α-synuclein-bearing glial cytoplasmic inclusions. The mostly negative trial outcomes highlight the importance of better understanding underlying disease mechanisms and improving preclinical models. Together with efforts to refine clinical measurement tools, innovative statistical methods, and developments in biomarker research, this will enhance the design of future neuroprotection trials in MSA and the likelihood of positive outcomes.< Réduire

Mots clés en anglais

Alpha-synuclein

Clinical trials

Disease-modifying therapies

Multiple system atrophy

URI

https://oskar-bordeaux.fr/handle/20.500.12278/188724

DOI

http://dx.doi.org/10.1007/s11910-024-01335-0

Métadonnées

Licence d’utilisation du document

Recent Advances in Clinical Trials in Multiple System Atrophy

Langue

Ce document a été publié dans

Résumé en anglais

Mots clés en anglais

URI

DOI

Unités de recherche

Métadonnées

Partager cette publication !

Licence d’utilisation du document

Recent Advances in Clinical Trials in Multiple System Atrophy

Langue

Ce document a été publié dans

Résumé en anglais

Mots clés en anglais

URI

DOI

Unités de recherche